论文部分内容阅读
目的:观察心静平治疗冠心病室性期前收缩的疗效。方法:将70例冠心病室性期前收缩患者随机分为2组,观察组(35例)服用心静平胶囊(4粒q8h),对照组(35例)服用美西律(10mgq6h),治疗室性期前收缩4周时,对比2组治疗效果。结果:通过心电图判断抗心律失常的疗效,观察组总有效率为82.86%,对照组为60%,2组差异显著(P<0.05),相关临床症状比较,观察组总有效率为85.71%,对照组为71.43%,2组差异不显著(P>0.05)。结论:心静平胶囊治疗冠心病室性期前收缩疗效肯定,能有效缓解临床症状。
Objective: To observe the effect of Xinjingping on ventricular premature contractions in patients with coronary heart disease. Methods: Seventy patients with premature ventricular contractions of coronary heart disease were randomly divided into two groups. The observation group (35 cases) took Xinjingping capsule (4 capsules q8h) and the control group (35 cases) took mexiletine (10mgq6h) Ventricular premature contraction 4 weeks, compared with two groups of treatment. Results: The total effective rate was 82.86% in the observation group and 60% in the control group by electrocardiogram to determine the antiarrhythmic effect. The difference between the two groups was significant (P <0.05). The total effective rate in the observation group was 85.71% The control group was 71.43%, there was no significant difference between the two groups (P> 0.05). Conclusion: Xinjingping Capsule treatment of coronary heart disease positive ventricular contraction effect, can effectively alleviate the clinical symptoms.